Benserazide is a carbohydrazide-based, peripherally acting inhibitor of aromatic L-amino acid decarboxylase or DOPA decarboxylase and a medication used in combination with levodopa (madopar) to treat Parkinson's disease, parkinsonism, and restless leg syndrome.

纯度：≥98%

CAS：322-35-0